Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,704 | Dovepress* | 3,524+ | 681 | 4,205 | |
| PubMed Central* | 180 | 59 | 239 | ||
| Totals | 3,704 | 740 | 4,444 | ||
| *Since 25 September 2020 | |||||
View citations on PubMed Central and Google Scholar